Adaptive Biotechnologies (ADPT) had the highest return on September 26, 2024 by a mid-cap US stock, returning 19.2%.

ASSET	DATE	% RETURN
Adaptive Biotechnologies (ADPT)	9/26/2024	19.22%
AXT (AXTI)	9/26/2024	15.49%
Guardian Pharmacy Services (GRDN)	9/26/2024	10.65%
Perpetua Resources (PPTA)	9/26/2024	10.22%
Galaxy Digital (GLXY)	9/26/2024	10.01%
Chemours (CC)	9/26/2024	7.49%
Immunitybio (IBRX)	9/26/2024	7.44%
CarMax (KMX)	9/26/2024	7.15%
Navitas Semiconductor (NVTS)	9/26/2024	7.02%
Kingsoft Cloud Holdings (KC)	9/26/2024	6.08%
H B Fuller (FUL)	9/26/2024	5.96%
Viridian Therapeutics (VRDN)	9/26/2024	5.68%
TAL Education (TAL)	9/26/2024	5.54%
Olin (OLN)	9/26/2024	5.43%
Vicor (VICR)	9/26/2024	5.4%
Taseko Mines (TGB)	9/26/2024	5.2%
Celanese (CE)	9/26/2024	5.17%
Melco Resorts & Entertainment (MLCO)	9/26/2024	5.14%
Legend Biotech (LEGN)	9/26/2024	5.12%
Lionsgate Studios Holding Corp (to be renamed Lionsgate Studios Corp) (LION)	9/26/2024	4.76%
Rigetti Computing (RGTI)	9/26/2024	4.15%
Silicon Laboratories (SLAB)	9/26/2024	4.08%
Plug Power (PLUG)	9/26/2024	4.04%
Bio-Rad Laboratories (BIO)	9/26/2024	4%
Dillard's (DDS)	9/26/2024	3.98%

Mid-cap stocks are treated as having a market cap between $2B and $10B.